Nomura Holdings Inc Takeda Pharmaceutical CO LTD Call Options Transaction History

Nomura Holdings Inc

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$13.36 - $15.43 $6.03 Million - $6.97 Million	451,500 New	451,500 $6.44 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $6.78 Million - $7.31 Million	443,850 New	443,850 $7.31 Million
Q3 2022 Nov 15, 2022	BUY	$12.8 - $28.65 $5.52 Million - $12.4 Million	431,550 New	431,550 $5.6 Million
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $1.86 Million - $2.21 Million	-111,250 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $1.45 Million - $2.26 Million	111,250 New	111,250 $1.69 Million

Q1 2020 May 14, 2020	SELL	$13.02 - $20.31 $2.23 Million - $3.48 Million	-171,250 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $828,999 - $1.02 Million	50,000 Added 41.24%	171,250 $3.03 Million
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $2.02 Million - $2.61 Million	121,250 New	121,250 $2.49 Million

341

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.8B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.